David R P Almeida1, Eric K Chin, Karim Rahim, James C Folk, Stephen R Russell. 1. *Vitreoretinal Service, Department of Ophthalmology and Visual Sciences, University of Iowa Hospitals and Clinics, Iowa City, Iowa; and †Department of Ophthalmology, Queen's University, Hotel Dieu Hospital, Kingston, Canada.
Abstract
PURPOSE: To analyze the factors that may predict the release of vitreomacular traction (VMT) and vitreomacular adhesion. METHODS: Retrospective case-control study of sixty-one patients with VMT imaged by optical coherence tomography over at least 3 months. Records from all patients seen at the University of Iowa from January 2012 to September 2013 were screened for the ICD9 code for VMT, vitreomacular adhesion, and epiretinal membrane (379.27 and 362.56). Release of VMT (R-VMT) was defined by resolution of patients' symptoms or traction by optical coherence tomography without surgical intervention or ocriplasmin injection. Individual factors or characteristics were evaluated by chi-square test. Using a binary logistic regression model, the potentially prognostic factors were evaluated for contribution to R-VMT. RESULTS: Of the 61 patients that met entry criteria, 21 (35%) developed R-VMT during optical coherence tomography follow-up, and 40 (65%) did not. Isolated inner retinal distortion without outer retinal involvement was significantly associated with R-VMT (P = 0.01). Vitreous injections were also associated with R-VMT (P = 0.02). CONCLUSION: Eyes with VMT and isolated inner retinal distortion and those receiving vitreous injections are more likely to develop VMT release without the need for surgical intervention or ocriplasmin treatment.
PURPOSE: To analyze the factors that may predict the release of vitreomacular traction (VMT) and vitreomacular adhesion. METHODS: Retrospective case-control study of sixty-one patients with VMT imaged by optical coherence tomography over at least 3 months. Records from all patients seen at the University of Iowa from January 2012 to September 2013 were screened for the ICD9 code for VMT, vitreomacular adhesion, and epiretinal membrane (379.27 and 362.56). Release of VMT (R-VMT) was defined by resolution of patients' symptoms or traction by optical coherence tomography without surgical intervention or ocriplasmin injection. Individual factors or characteristics were evaluated by chi-square test. Using a binary logistic regression model, the potentially prognostic factors were evaluated for contribution to R-VMT. RESULTS: Of the 61 patients that met entry criteria, 21 (35%) developed R-VMT during optical coherence tomography follow-up, and 40 (65%) did not. Isolated inner retinal distortion without outer retinal involvement was significantly associated with R-VMT (P = 0.01). Vitreous injections were also associated with R-VMT (P = 0.02). CONCLUSION: Eyes with VMT and isolated inner retinal distortion and those receiving vitreous injections are more likely to develop VMT release without the need for surgical intervention or ocriplasmin treatment.
Authors: D H W Steel; L Downey; K Greiner; H Heimann; T L Jackson; Z Koshy; D A H Laidlaw; L Wickham; Y Yang Journal: Eye (Lond) Date: 2016-01-15 Impact factor: 3.775
Authors: José Javier García-Medina; Mónica Del-Río-Vellosillo; Elena Rubio-Velázquez; María Dolores López-Bernal; Juan José Zafra-Pérez Journal: Am J Ophthalmol Case Rep Date: 2019-02-22